首页|急性冠脉综合征患者外周血miR-378a-3p的表达及其诊断价值

急性冠脉综合征患者外周血miR-378a-3p的表达及其诊断价值

扫码查看
目的:探讨急性冠脉综合征(ACS)患者外周血miR-378a-3p的表达及其诊断价值。方法:收集ACS患者和健康人(contro1)血清各3份,进行基因芯片检测筛选发现miR-378a-3p差异表达最为显著。利用网络药理学分析miR-378a-3p与心肌缺血的相关性。构建小鼠心肌缺血再灌注(IR)模型,按缺血再灌注时间不同分为假手术(sham)组、I/R 1h组、I/R3h组、I/R 6h组、I/R 12h组,检测外周血miR-378a-3p表达水平以及心肌肌钙蛋白T(cTnT)浓度水平。收集ACS患者(101例)和同期健康体检人群(49例),进行实时定量PCR,检测miR-378a-3p在ACS患者的表达。采用受试者工作特征曲线(ROC)分析miR-378a-3p诊断ACS的诊断效能,并对ACS进行风险评估。结果:基因芯片结果显示miR-378a-3p在ACS患者外周血中表达升高。网络药理学分析提示,miR-378a-3p与心肌缺血存在共同靶点且miR-378a-3p可能通过细胞凋亡和血管生成途径干预心肌缺血,有作为心肌缺血标志物的可能。动物实验证实miR-378a-3p表达量随心肌缺血时间变化逐渐上调且在6h时表达明显升高,且miR-378a-3p表达水平较cTnT更早在心肌缺血中出现高表达。临床数据分析表明,同健康对照组比较,ACS患者血清中的miR-378a-3p在发生ACS的临床症状后,在短时间内可以显著升高。miR-378a-3p作为ACS的特异性诊断指标时,曲线下面积(AUC)为0。8476(95%可信区间为0。7749-0。9204,P<0。001),约登指数为0。6981,采用0。214作为cut-off值,miR-378a-3p诊断ACS的灵敏度和特异度分别为86。14%和83。76%。进一步的研究显示,在缺血的转化过程中,根据疾病分类的不同,结果显示miR-378a-3p的表达趋势也不同,在不稳定型心绞痛(UA)和心肌梗死(MI)组中,miR-378a-3p都显著上调(P<0。001),同MI患者相比,UA患者miR-378a-3p表达上调更显著(P<0。05),提示在诊断和判断ACS的分类中有较好的价值。结论:ACS患者外周血中miR-378a-3p表达升高是ACS发生的独立危险因素,早期检测miR-378a-3p有助于预测ACS的发病情况。
Expression of miR-378a-3p in Peripheral Blood of Patients with Acute Coronary Syndrome and its Diagnostic Value
Objective:To investigate the expression of miR-378a-3p in peripheral blood of patients with acute coronary syndrome(ACS)and its diagnostic value.Methods:Three sera each from patients with acute coronary syndrome(ACS)and healthy individuals(control)were collected and screened by gene microarray to find the most significant differential expression of miR-378a-3p.The correlation between miR-378a-3p and myocardial ischemia was analyzed using network pharmacology.A mouse myocardial ischemia reperfusion(IR)model was constructed and divided into sham operation,I/R 1 h,I/R 3 h,I/R 6 h,and I/R 12 h groups according to the time of ischemia and reperfusion,and the miR-378a-3p expression level in peripheral blood as well as the concentration level of cardiac muscle troponin T(cTnT)were detected.Patients with ACS(101 cases)and the same period of healthy physical examination population(49 cases)were collected and real-time quantitative PCR was performed to detect the expression of miR-378a-3p in patients with ACS.The diagnostic efficacy of miR-378a-3p for the diagnosis of ACS was analyzed by using the receiver operating characteristic curve(ROC),and the risk assessment of ACS was performed.Results:Gene microarray results showed that miR-378a-3p expression was elevated in the peripheral blood of patients with ACS.Network pharmacological analysis suggested that miR-378a-3p and myocardial ischemia share common targets and that miR-378a-3p may intervene in myocardial ischemia through apoptosis and angiogenic pathways,which may be used as a marker for myocardial ischemia.Animal experiments demonstrated that miR-378a-3p expression was gradually up-regulated with the duration of myocardial ischemia,and the expression was significantly increased at 6 h.Moreover,the expression level of miR-378a-3p appeared to be higher in myocardial ischemia at an earlier time than that of cTnT.Clinical data analysis showed that miR-378a-3p in the serum of patients with ACS could be significantly elevated within a short period of time after the clinical symptoms of ACS compared with healthy controls.When miR-378a-3p was used as a specific diagnostic indicator for ACS,the area under the curve(AUC)was 0.8476(95%confidence interval 0.7749-0.9204,P<0.001),the Yoden index was 0.6981,and the sensitivity and specificity of miR-378a-3p for diagnosing ACS were 0.214 adopted as the cut-off value,respectively were 86.14%and 83.76%.Further studies showed that during the transformation of ischemia,depending on the disease classification,the results showed different trends of miR-378a-3p expression.miR-378a-3p was significantly upregulated in both the unstable angina(UA)and myocardial infarction(MI)groups(P<0.001),and compared with MI,the upregulation of miR-378a-3p expression in peripheral blood of patients with UA was more significantly(P<0.05),suggesting a better value in diagnosis and judgment of ACS classification.Conclusion:Elevated miR-378a-3p expression in peripheral blood of patients with ACS is an independent risk factor for the development of ACS,and early detection of miR-378a-3p can help predict the development of ACS.

Acute coronary syndromePeripheral bloodmiR-378a-3pDiagnostic value

张春生、焦甜甜、许铃浩、王亮、程静、李纪明

展开 >

南京医科大学上海东方临床医学院 上海 200120

同济大学附属东方医院心内科 上海 200120

急性冠脉综合征 外周血 miR-378a-3p 诊断价值

2024

现代生物医学进展
黑龙江省森工总医院 哈尔滨医科大学附属第四医院

现代生物医学进展

CSTPCD
影响因子:0.755
ISSN:1673-6273
年,卷(期):2024.24(11)